Dapoxetine can treat premature ejaculation, but is contraindicated in allergy, patients with pathologic heart disease, bipolar disorder, history of major depression, and moderate/severe liver damage. Dapoxetine (dapoxetine) Dapoxetine belongs to the group of selective 5-hydroxytryptamine reuptake inhibitors (SSRIs), and is the only drug approved by China’s State Food and Drug Administration (CFDA) for the treatment of premature ejaculation (PE) with an indication. Oral administration of 30mg of this drug about 1~2h before sexual intercourse increased the ejaculation latency time by 2.5 times, and ejaculation control and satisfaction were significantly improved.Both primary and secondary premature ejaculation can be treated with dapoxetine. The product is contraindicated in individuals who are hypersensitive to dapoxetine, patients with pathologic heart disease, individuals with a history of mania/major depression, and individuals with moderate/severe hepatic impairment. Common adverse reactions include diarrhea, nasal congestion, dizziness and headache. Please use under the supervision of a physician and do not use without authorization.